Indivior PLC (INDV)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Buprenorphine-based Prescription Drugs	879.29M
Buprenorphine-based Prescription Drugs Growth	20.21%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	733.68M
United States Growth	23.63%
Rest of World	141.59M
Rest of World Growth	6.34%
United Kingdom	4.02M
United Kingdom Growth	-17.42%